Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Long-Term Survival in High-Grade Serous Ovarian Cancer Compared With the General US Population: A 30-Year Landmark Analysis.

JCO oncology advances·2026

Same author

Effect of a Symptom Surveillance and Collaborative Care Intervention on Palliative Care Utilization.

Journal of pain and symptom management·2026

Same author

Electronic health record-facilitated symptom surveillance and collaborative care intervention in oncology (E2C2): a cluster-randomised, population-level, stepped-wedge, pragmatic trial.

The Lancet. Oncology·2025

Same author

From reporting to relating: Reimagining ePROMs in cancer symptom management.

Social science & medicine (1982)·2025

Same author

Sustainability of Complex Interventions: Recommendations From a Pragmatic Clinical Trial to Manage Cancer Symptoms.

Nursing research·2025

Same author

Barriers and facilitators to using practice facilitators to implement a remote cancer symptom management intervention: a mixed methods study.

BMC health services research·2025

Search research articles

Related Experiment Video

Updated: May 22, 2026

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

Recognizing and treating ovarian cancer.

Bobbie S Gostout¹, Deirdre R Pachman, Rebecca Lechner

¹Mayo Clinic, USA.

Minnesota Medicine

|May 23, 2012

Summary

Early diagnosis of ovarian cancer is crucial due to its high mortality rate. This article highlights methods for early detection and treatment of this deadly gynecologic cancer.

Area of Science:

Gynecologic Oncology
Oncology
Women's Health

Background:

Ovarian cancer is the fifth leading cause of cancer death in women.
It is the deadliest gynecologic cancer, often diagnosed at late stages.
No definitive screening test currently exists.

Observation:

A recent consensus statement provides guidance for identifying at-risk women.
Early diagnosis is critical for improving patient outcomes.
This article emphasizes the importance of timely detection.

Findings:

The article reviews current and emerging treatments for ovarian cancer.
It discusses diagnostic strategies and the role of physicians in early identification.
The collaborative role of primary care physicians and gynecologic oncologists is examined.

More Related Videos

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Published on: March 25, 2019

Related Experiment Videos

Last Updated: May 22, 2026

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence

Published on: November 2, 2014

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting

Published on: March 25, 2019

Implications:

Improved early detection can lead to better prognosis for ovarian cancer patients.
Enhanced physician awareness and diagnostic approaches are vital.
Further research into screening and early intervention is warranted.